Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Market Cap	115.08B +3.5%
Revenue (ttm)	42.61B +1.4%
Net Income	2.66B +28.7%
EPS	16.76 +28.4%
Shares Out	158.13M
PE Ratio	43.43
Forward PE	33.19
Dividend	5.00 (0.69%)
Ex-Dividend Date	Feb 10, 2026

Volume	183,000
Average Volume	204,475
Open	755.95
Previous Close	748.30
Day's Range	719.90 - 756.05
52-Week Range	537.30 - 851.80
Beta	0.37
RSI	55.98
Earnings Date	May 26, 2026

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2019
• Employees: 2,139
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JUBLINGREA

Financial Performance

In fiscal year 2025, Jubilant Ingrevia's revenue was 41.78 billion, an increase of 1.01% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.